PUVA Therapy vs Topical Corticosteroids

PUVA combines a light-sensitising medicine with carefully measured UVA exposure. It is delivered in a dermatology setting and may be considered when disease covers larger areas or has not settled with simpler measures. Topical corticosteroids are anti-inflammatory medicines applied to affected skin, making them useful for focused flares and accessible home treatment when prescribed.

PUVA treats selected widespread or persistent skin disease with controlled ultraviolet exposure, while topical corticosteroids calm inflammation directly where they are applied.

PUVA may be discussed when patches are widespread, thickened, or repeatedly returning despite appropriate topical treatment. It can be practical when applying medicine over a large body area is difficult. The dermatologist must first check the diagnosis, medicines, light sensitivity, and ability to attend scheduled sessions. Protective eyewear and exposure instructions form part of the treatment plan.

Topical corticosteroids may suit a small or clearly defined area that needs inflammation controlled without clinic-based light exposure. The product strength, amount, body site, and treatment length matter: thin skin such as the face and skin folds needs different guidance from thicker skin on the palms or soles. Application should follow the prescribed plan rather than continuing automatically after the flare improves.

PUVA can cause redness, warmth, tanning, or irritation, and the sensitising medicine can increase light sensitivity. Eyes and treated skin need protection as instructed, including around treatment sessions. Topical corticosteroids can irritate skin and, with unsuitable strength or prolonged unsupervised use, may thin the skin or make some infections harder to recognise. Tell the clinician about new burning, blistering, spreading rash, or eye symptoms.

Neither treatment should be selected until an uncertain rash has been assessed. A rash that is rapidly spreading, painful, blistered, infected-looking, or associated with fever needs prompt medical review. A clinician may instead recommend a different anti-inflammatory medicine, an antimicrobial treatment, another light approach, or testing such as a skin sample, depending on the diagnosis.

The decision usually starts with the diagnosis and the pattern of disease, then considers affected sites, extent, thickness, prior response, daily routine, pregnancy or breastfeeding status, other medicines, and follow-up access. The clinician may use a topical corticosteroid for a defined flare and reserve PUVA for a broader or more persistent pattern, or use a staged plan. Bring a list of medicines and describe what has helped, irritated, or failed before.